Peter Mac offers clinical trial central testing to a range of international and local pharmaceutical and diagnostic companies, CROs and research organisations including hospitals and universities.
Our laboratories are NATA accredited and are experienced in a range of testing techniques, logistics management, project management, quality control and documentation required for clinical trials.
Why Peter Mac?
The Centre for Clinical Cancer Genomics provides capabilities in clinical care, research and clinical testing ensure that the highest level of testing is available. We are able to meet delivery deadlines and provide the appropriate level of support and management for clinical trials testing.
Services
Clinical trial testing including:
- germline
- somatic
- haematology
- custom assays
- support for data analytics.
Peter Mac participates in trials for new diagnostic instrumentation and is available to perform safety monitoring testing and other pathology test for clinical trials where required.
Example of services available
| Type | Testing available | Example tests |
| Germline | Next Gen Sequencing PCR | BRCA1 & 2, Ashkenazi MLH1, MSH2, MSH6, PMS2 |
| Somatic | FISH Next Gen Sequencing MET Immunohistochemistry | EGFR KRAS NRAS TP53 HER2 |
| Haematology | CLL | |
| Data Analytics | Peter Mac can review NGS output with PathOS: a decision support application for the analysis and reporting of NGS data |
Related Experts
Stephen Fox, Director of Pathology
CONTACT
Clinical Trials Business Development Manager
